We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urine Dipstick Accurately Predicts Renal Failure

By LabMedica International staff writers
Posted on 31 May 2012
The presence of excess protein in a common urine test is an effective prognostic marker of acute renal failure in patients with severe sepsis. More...


A urine dipstick test is routinely done as part of a urinalysis to help diagnose urinary tract infections, kidney disease, diabetes, and sepsis, the deadly bloodstream infection.

At the Henry Ford Hospital (Detroit, MI, USA) scientists analyzed data from 328 sepsis patients with no previous history of protein in the urine. After a urine sample was taken, a specially treated chemical strip was placed into the sample. The presence of such things as white blood cells, protein, or glucose in the urine is indicated by patches on the dipstick, which change color.

Many studies have shown the dipstick test to be a rapid detector for identifying urinary tract infections. However, this the first time the dipstick test has been evaluated for its accuracy of identifying renal failure in sepsis patients. They found the urine dipstick test predicted the presence of renal failure in 55% of these patients.

Javier Neyra, MD, a third-year resident at Henry Ford and the study's lead author, said, "The dipstick test excess protein, or proteinuria, resulted in fewer false positives and a greater threshold for detecting more severe renal failure compared to other biomarkers. Ultimately, the test may provide timely and early diagnosis of renal failure before substantial damage has already been done. This is a useful test that is widely available and inexpensive." The results of the study were presented at the National Kidney Foundation's annual meeting May 9-13, 2012, held in Washington DC, USA).

Related Links:
Henry Ford Hospital





Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.